Attovia Therapeutics, Inc. · NASDAQ:ATTO

Attovia Therapeutics, Inc. insider trades

Attovia Therapeutics, Inc.'s insiders made 11 buys and 66 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

DateInsiderTradeSharesPriceFiling
Aug 6, 2026Goldman Sachs Asset Management, L.P.Buy500,000US$17Form 4
Aug 6, 2026Walsh ColinBuy500,000US$17Form 4
Aug 6, 2026Goldman Sachs & Co. LLCBuy500,000US$17Form 4
Aug 6, 2026venBio Global Strategic Fund IV, L.P.Buy382,352US$17Form 4
Aug 6, 2026Green JeremyBuy400,000US$17Form 4
Aug 6, 2026SanofiBuy300,000US$17Form 4
Aug 6, 2026Green JeremyBuy200,000US$17Form 4
Aug 6, 2026Fhmls XI, L.P.Buy588,235US$17Form 4
Aug 5, 2026Walsh ColinSale200US$22Form 4
Aug 5, 2026Walsh ColinBuy85,000US$21Form 4

Attovia Therapeutics, Inc. shareholders